Complete Filing Data
CVRx, Inc. reported Stockholders Equity of $39.32 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean CVRx, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income * | -$53.3M | -$60.0M | -$41.2M | -$41.4M | -$43.1M | -$14.1M |
| Selling General And Administrative Expense | $88.5M | $91.3M | $64.5M | $50.0M | $27.9M | $9.7M |
| Revenue From Contract With Customer Excluding Assessed Tax | $56.7M | $51.3M | $39.3M | $22.5M | $13.0M | $6.1M |
| Research And Development Expense | $11.1M | $11.1M | $11.6M | $10.0M | $7.5M | $6.4M |
| Other Nonoperating Income Expense | $3.8M | $4.0M | $3.9M | $1.4M | -$14.8M | -$40.0K |
| Operating Income Loss | -$51.3M | -$59.5M | -$43.1M | -$42.5M | -$26.0M | -$11.5M |
| Operating Expenses | $99.6M | $102.4M | $76.1M | $60.0M | $35.4M | $16.1M |
| Income Tax Expense Benefit | -$18.0K | $55.0K | $147.0K | $109.0K | $91.0K | $85.0K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$53.3M | -$59.9M | -$41.1M | -$41.3M | -$43.0M | -$14.0M |
| Gross Profit | $48.3M | $43.0M | $33.0M | $17.5M | $9.4M | $4.6M |
| Cost Of Revenue | $8.3M | $8.3M | $6.3M | $5.0M | $3.6M | $1.4M |
| Comprehensive Income Net Of Tax | -$53.3M | -$60.0M | -$41.2M | -$41.4M | -$43.1M | -$14.1M |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $3.0K | $1.0K | -$9.0K | -$8.0K | -$1.0K | |
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | $2.0K | $1.0K | -$9.0K | -$8.0K | -$1.0K | |
| Income Taxes Paid | $0.00 | $4.0K | $5.0K | $2.0K | $10.0K | |
| Interest Expense | $1.8M | $165.0K | $2.2M | $2.5M | ||
| Interest Expense Nonoperating | $5.8M | $4.4M | $1.8M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$12.9M | -$14.7M | -$13.8M | -$13.1M | -$14.0M | -$22.2M | -$9.0M | -$11.7M | -$11.4M | -$9.8M | -$11.1M | -$10.0M | -$6.1M | -$17.7M | -$8.6M | -$3.2M | -$3.7M |
| Selling General And Administrative Expense | $21.9M | $23.4M | $21.2M | $21.6M | $21.1M | $28.3M | $15.7M | $16.5M | $15.4M | $12.7M | $12.5M | $10.8M | $8.1M | $5.6M | $4.5M | $2.3M | $1.8M |
| Revenue From Contract With Customer Excluding Assessed Tax | $14.7M | $13.6M | $12.3M | $13.4M | $11.8M | $10.8M | $10.5M | $9.5M | $8.0M | $6.2M | $5.0M | $4.1M | $3.4M | $3.1M | $2.9M | $997.0K | $1.3M |
| Research And Development Expense | $3.1M | $2.5M | $2.5M | $2.5M | $2.8M | $3.1M | $2.7M | $3.3M | $3.4M | $2.3M | $2.4M | $2.3M | $1.7M | $2.3M | $1.8M | $1.5M | $2.1M |
| Other Nonoperating Income Expense | $875.0K | $1.1M | $1.1M | $917.0K | $944.0K | $1.0M | $1.1M | $616.0K | $1.1M | $328.0K | -$34.0K | -$57.0K | $1.8M | -$11.4M | -$3.8M | $455.0K | $33.0K |
| Operating Income Loss | -$12.3M | -$14.4M | -$13.4M | -$13.0M | -$14.0M | -$22.2M | -$9.5M | -$11.8M | -$12.2M | -$10.1M | -$11.0M | -$9.9M | -$7.3M | -$5.7M | -$4.2M | -$3.0M | -$3.1M |
| Operating Expenses | $25.0M | $25.8M | $23.7M | $24.1M | $23.9M | $31.4M | $18.3M | $19.7M | $18.8M | $15.0M | $14.8M | $13.0M | $9.8M | $7.9M | $6.2M | $3.8M | $4.0M |
| Income Tax Expense Benefit | -$3.0K | -$3.0K | -$5.0K | $47.0K | $41.0K | $38.0K | $40.0K | $34.0K | $34.0K | $32.0K | $23.0K | $26.0K | $23.0K | $26.0K | $17.0K | $19.0K | $22.0K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$12.9M | -$14.7M | -$13.8M | -$13.1M | -$14.0M | -$22.1M | -$9.0M | -$11.6M | -$11.3M | -$9.8M | -$11.0M | -$10.0M | -$6.1M | -$17.7M | -$8.6M | -$3.2M | -$3.6M |
| Gross Profit | $12.8M | $11.5M | $10.3M | $11.1M | $9.9M | $9.2M | $8.8M | $8.0M | $6.7M | $4.8M | $3.8M | $3.1M | $2.5M | $2.2M | $2.0M | $785.0K | $905.0K |
| Cost Of Revenue | $1.9M | $2.1M | $2.0M | $2.2M | $1.9M | $1.6M | $1.7M | $1.5M | $1.3M | $1.3M | $1.2M | $949.0K | $876.0K | $913.0K | $867.0K | $212.0K | $345.0K |
| Comprehensive Income Net Of Tax | -$12.9M | -$14.7M | -$13.8M | -$13.1M | -$14.0M | -$22.2M | -$9.0M | -$11.6M | -$11.4M | -$9.8M | -$11.1M | -$10.0M | -$6.1M | -$17.7M | -$8.6M | -$3.2M | -$3.7M |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$1.0K | $2.0K | $1.0K | $2.0K | -$3.0K | -$21.0K | $17.0K | $3.0K | -$8.0K | -$7.0K | -$6.0K | -$3.0K | -$1.0K | -$4.0K | $14.0K | -$11.0K | |
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | -$1.0K | $3.0K | $2.0K | -$3.0K | -$21.0K | $17.0K | $3.0K | -$8.0K | -$7.0K | -$6.0K | -$3.0K | -$1.0K | -$4.0K | $14.0K | -$11.0K | ||
| Income Taxes Paid | $0.00 | $0.00 | $0.00 | $0.00 | $1.0K | ||||||||||||
| Interest Expense | $960.0K | $499.0K | $481.0K | $240.0K | $0.00 | $0.00 | $0.00 | $614.0K | $608.0K | $601.0K | $621.0K | $618.0K | |||||
| Interest Expense Nonoperating | $1.5M | $1.5M | $1.5M | $958.0K | $959.0K | $960.0K | $499.0K | $481.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity | $39.3M | $71.1M | $75.9M | $109.2M | $146.0M | -$293.2M | -$279.0M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $75.7M | $105.9M | $90.6M | $106.2M | $142.1M | $59.1M | $25.7M |
| Accounts Receivable Net Current | $10.7M | $9.3M | $7.6M | $5.5M | $2.6M | $1.3M | |
| Retained Earnings Accumulated Deficit | -$590.7M | -$537.3M | -$477.4M | -$436.2M | -$394.8M | -$351.7M | |
| Property Plant And Equipment Net | $2.2M | $2.5M | $1.8M | $1.7M | $1.4M | $410.0K | |
| Prepaid Expense And Other Assets Current | $3.1M | $2.5M | $3.0M | $4.2M | $2.6M | $605.0K | |
| Other Liabilities Noncurrent | $2.0M | $1.4M | $1.0M | $805.0K | $681.0K | $777.0K | |
| Other Assets Noncurrent | $26.0K | $27.0K | $27.0K | $27.0K | $26.0K | $26.0K | |
| Liabilities Current | $13.3M | $10.8M | $7.9M | $8.1M | $5.9M | $8.0M | |
| Liabilities And Stockholders Equity | $104.8M | $133.4M | $115.2M | $124.9M | $152.5M | $64.8M | |
| Liabilities | $65.5M | $62.4M | $39.3M | $15.8M | $6.6M | $28.0M | |
| Inventory Net | $12.2M | $12.1M | $11.0M | $7.0M | $3.9M | $3.3M | |
| Common Stock Value | $263.0K | $253.0K | $209.0K | $207.0K | $204.0K | $4.0K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$30.2M | $15.4M | -$15.6M | -$35.9M | $83.0M | $33.4M | |
| Cash And Cash Equivalents At Carrying Value | $75.7M | $105.9M | $90.6M | $106.2M | $142.1M | $59.1M | |
| Assets Current | $101.6M | $129.8M | $112.1M | $122.9M | $151.1M | $64.3M | |
| Assets | $104.8M | $133.4M | $115.2M | $124.9M | $152.5M | $64.8M | |
| Additional Paid In Capital Common Stock | $629.9M | $608.4M | $553.3M | $545.4M | $540.7M | $58.6M | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$203.0K | -$206.0K | -$207.0K | -$207.0K | -$198.0K | -$190.0K | |
| Accrued Liabilities Current | $9.5M | $8.2M | $6.0M | $6.4M | $5.4M | $3.6M | |
| Accounts Payable Current | $3.8M | $2.6M | $1.9M | $1.7M | $510.0K | $483.0K | |
| Operating Lease Liability Noncurrent | $638.0K | $877.0K | $1.2M | $117.0K | $0.00 | ||
| Operating Lease Right Of Use Asset | $878.0K | $1.1M | $1.3M | $334.0K | $0.00 | ||
| Long Term Debt Noncurrent | $49.5M | $49.3M | $29.2M | $6.7M | $0.00 | $19.3M | |
| Allowance For Doubtful Accounts Receivable Current | $871.0K | $780.0K | $508.0K | $679.0K | $0.00 | ||
| Gain Loss On Sale Of Property Plant Equipment | -$86.0K | $0.00 | -$4.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $48.1M | $57.9M | $71.1M | $65.2M | $55.2M | $66.3M | $82.8M | $90.0M | $99.6M | $118.2M | $127.1M | $136.8M | $155.8M | -$318.9M | -$301.8M | -$289.9M | -$286.5M | -$282.8M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $85.1M | $95.0M | $102.7M | $100.2M | $70.4M | $80.1M | $83.0M | $90.8M | $103.3M | $110.0M | $121.3M | $131.2M | $170.9M | $47.1M | $54.0M | $63.3M | $18.8M | |
| Accounts Receivable Net Current | $8.2M | $7.2M | $9.0M | $9.0M | $8.6M | $8.5M | $6.4M | $6.7M | $6.4M | $5.3M | $3.6M | $3.7M | $3.4M | $2.2M | ||||
| Retained Earnings Accumulated Deficit | -$578.7M | -$565.8M | -$551.1M | -$526.7M | -$513.6M | -$499.6M | -$468.2M | -$459.2M | -$447.6M | -$425.6M | -$415.8M | -$404.7M | -$384.2M | -$378.1M | ||||
| Property Plant And Equipment Net | $2.4M | $2.3M | $2.4M | $2.6M | $2.8M | $2.5M | $1.7M | $1.8M | $1.8M | $1.7M | $1.6M | $1.7M | $943.0K | $820.0K | ||||
| Prepaid Expense And Other Assets Current | $3.2M | $2.2M | $2.8M | $2.8M | $1.8M | $2.7M | $3.3M | $3.5M | $2.6M | $3.1M | $1.2M | $2.1M | $2.9M | $1.7M | ||||
| Other Liabilities Noncurrent | $1.9M | $1.7M | $1.6M | $1.4M | $1.3M | $1.2M | $960.0K | $885.0K | $815.0K | $761.0K | $732.0K | $706.0K | $941.0K | $884.0K | ||||
| Other Assets Noncurrent | $26.0K | $26.0K | $26.0K | $26.0K | $26.0K | $26.0K | $26.0K | $27.0K | $27.0K | $26.0K | $26.0K | $26.0K | $67.0K | $26.0K | ||||
| Liabilities Current | $11.2M | $9.7M | $8.5M | $10.9M | $9.1M | $8.4M | $7.4M | $8.9M | $8.0M | $7.4M | $5.9M | $6.6M | $8.9M | $25.0M | ||||
| Liabilities And Stockholders Equity | $111.3M | $119.6M | $129.6M | $127.7M | $96.0M | $106.2M | $106.4M | $115.0M | $122.7M | $126.6M | $134.0M | $144.4M | $181.7M | $55.1M | ||||
| Liabilities | $63.3M | $61.6M | $60.2M | $62.5M | $40.7M | $39.9M | $23.6M | $25.0M | $23.0M | $8.3M | $6.9M | $7.6M | $25.9M | $44.0M | ||||
| Inventory Net | $11.4M | $11.7M | $11.7M | $11.9M | $11.2M | $11.1M | $10.9M | $10.9M | $8.2M | $6.1M | $5.8M | $5.3M | $3.4M | $3.2M | ||||
| Common Stock Value | $262.0K | $261.0K | $261.0K | $242.0K | $217.0K | $216.0K | $208.0K | $208.0K | $207.0K | $206.0K | $206.0K | $205.0K | $204.0K | $4.0K | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$3.3M | -$10.5M | -$2.9M | -$10.9M | -$5.1M | |||||||||||||
| Cash And Cash Equivalents At Carrying Value | $85.1M | $95.0M | $102.7M | $100.2M | $70.4M | $80.1M | $83.0M | $90.8M | $103.3M | $110.0M | $121.3M | $131.2M | $170.9M | $47.1M | ||||
| Assets Current | $107.9M | $116.1M | $126.1M | $123.9M | $92.0M | $102.3M | $103.6M | $112.0M | $120.6M | $124.4M | $131.9M | $142.2M | $180.7M | $54.2M | ||||
| Assets | $111.3M | $119.6M | $129.6M | $127.7M | $96.0M | $106.2M | $106.4M | $115.0M | $122.7M | $126.6M | $134.0M | $144.4M | $181.7M | $55.1M | ||||
| Additional Paid In Capital Common Stock | $626.7M | $623.7M | $620.4M | $591.8M | $568.8M | $565.8M | $551.0M | $549.2M | $547.2M | $543.9M | $543.0M | $541.5M | $539.9M | $59.3M | ||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$204.0K | -$203.0K | -$205.0K | -$208.0K | -$210.0K | -$210.0K | -$208.0K | -$187.0K | -$204.0K | -$219.0K | -$211.0K | -$204.0K | -$197.0K | -$195.0K | ||||
| Accrued Liabilities Current | $7.6M | $6.7M | $5.8M | $7.7M | $5.6M | $5.8M | $6.3M | $6.0M | $6.0M | $6.1M | $5.3M | $5.0M | $5.0M | $3.8M | ||||
| Accounts Payable Current | $3.6M | $3.0M | $2.8M | $3.3M | $3.5M | $2.6M | $1.1M | $2.9M | $2.0M | $1.3M | $608.0K | $1.6M | $541.0K | $888.0K | ||||
| Operating Lease Liability Noncurrent | $730.0K | $819.0K | $802.0K | $951.0K | $1.0M | $1.1M | $916.0K | $946.0K | $59.0K | $175.0K | $250.0K | $304.0K | $512.0K | |||||
| Operating Lease Right Of Use Asset | $963.0K | $1.0M | $994.0K | $1.1M | $1.2M | $1.3M | $1.1M | $1.1M | $277.0K | $391.0K | $465.0K | $522.0K | ||||||
| Long Term Debt Noncurrent | $49.5M | $49.4M | $49.3M | $49.2M | $29.3M | $29.3M | $14.3M | $14.3M | $14.2M | $16.2M | $18.1M | |||||||
| Allowance For Doubtful Accounts Receivable Current | $871.0K | $871.0K | $810.0K | $522.0K | $656.0K | $647.0K | $506.0K | $602.0K | $641.0K | |||||||||
| Gain Loss On Sale Of Property Plant Equipment | $0.00 | -$4.0K | $0.00 |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Share Based Compensation | $11.1M | $19.1M | $6.3M | $3.9M | $1.9M | $132.0K |
| Proceeds From Stock Options Exercised | $793.0K | $2.7M | $728.0K | $184.0K | $23.0K | $0.00 |
| Payments To Acquire Property Plant And Equipment | $580.0K | $1.4M | $591.0K | $685.0K | $1.2M | $311.0K |
| Net Cash Provided By Used In Operating Activities | -$40.2M | -$39.1M | -$39.0M | -$42.7M | -$27.7M | -$16.1M |
| Net Cash Provided By Used In Investing Activities | -$580.0K | -$1.4M | -$591.0K | -$685.0K | -$1.2M | -$311.0K |
| Net Cash Provided By Used In Financing Activities | $10.5M | $55.9M | $24.0M | $7.5M | $111.9M | $49.8M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $543.0K | -$531.0K | -$1.3M | $1.6M | $2.0M | $226.0K |
| Increase Decrease In Inventories | $98.0K | $1.1M | $4.0M | $3.1M | $537.0K | $1.3M |
| Increase Decrease In Accrued Liabilities | $1.8M | $2.6M | -$170.0K | $873.0K | $2.2M | -$838.0K |
| Increase Decrease In Accounts Receivable | $1.4M | $1.7M | $2.0M | $2.9M | $1.3M | $562.0K |
| Increase Decrease In Accounts Payable | $1.3M | $698.0K | $165.0K | $1.2M | $27.0K | $46.0K |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $5.0K | -$1.0K | $3.0K | -$9.0K | -$8.0K | -$5.0K |
| Proceeds From Stock Plans | $753.0K | $803.0K | $935.0K | $587.0K | $0.00 | |
| Proceeds From Issuance Of Common Stock | $9.0M | $32.5M | $0.00 | $0.00 | $133.2M | $0.00 |
| Proceeds From Long Term Lines Of Credit | $0.00 | $20.0M | $22.5M | $7.5M | $0.00 | |
| Payments Of Financing Costs | $0.00 | $152.0K | $179.0K | $778.0K | $0.00 | |
| Payments Related To Reverse Stock Split | $0.00 | $1.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|
| Share Based Compensation | $2.5M | $11.1M | $1.7M | $793.0K | $61.0K |
| Proceeds From Stock Options Exercised | $417.0K | $815.0K | $128.0K | $48.0K | $2.0K |
| Payments To Acquire Property Plant And Equipment | $114.0K | $917.0K | $240.0K | $293.0K | $101.0K |
| Net Cash Provided By Used In Operating Activities | -$12.8M | -$10.9M | -$10.2M | -$10.6M | -$5.0M |
| Net Cash Provided By Used In Investing Activities | -$114.0K | -$917.0K | -$240.0K | -$293.0K | -$101.0K |
| Net Cash Provided By Used In Financing Activities | $9.6M | $1.4M | $7.6M | $48.0K | $2.0K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $270.0K | -$345.0K | -$1.6M | -$485.0K | $454.0K |
| Increase Decrease In Inventories | -$435.0K | $73.0K | $1.3M | $1.4M | -$314.0K |
| Increase Decrease In Accrued Liabilities | -$2.3M | -$82.0K | -$398.0K | -$596.0K | -$55.0K |
| Increase Decrease In Accounts Receivable | -$256.0K | $944.0K | $930.0K | $1.1M | $431.0K |
| Increase Decrease In Accounts Payable | $169.0K | $724.0K | $277.0K | $1.1M | $364.0K |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $1.0K | -$3.0K | $3.0K | -$6.0K | -$4.0K |
| Proceeds From Stock Plans | |||||
| Proceeds From Issuance Of Common Stock | $9.2M | $547.0K | $0.00 | ||
| Proceeds From Long Term Lines Of Credit | $0.00 | $7.5M | $0.00 | ||
| Payments Of Financing Costs | $0.00 | $60.0K | $0.00 | ||
| Payments Related To Reverse Stock Split |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Diluted EPS * | -$2.04 | -$2.65 | -$1.99 | -$2.02 | -$4.16 | -$37.01 |
| Weighted Average Number Of Diluted Shares Outstanding | 26.1M | 22.6M | 20.8M | 20.5M | 10.4M | |
| Weighted Average Number Of Shares Outstanding Basic | 26.1M | 22.6M | 20.8M | 20.5M | 10.4M | |
| Earnings Per Share Basic | $-2.04 | $-2.65 | $-1.99 | $-2.02 | $-4.16 | |
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 625.2M |
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 |
| Common Stock Shares Outstanding | 26.3M | 25.3M | 20.9M | 20.7M | 20.4M | 360.4K |
| Common Stock Shares Issued | 26.3M | 25.3M | 20.9M | 20.7M | 20.4M | 360.4K |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 10.4M | 387.1K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.49 | -$0.57 | -$0.53 | -$0.57 | -$0.65 | -$1.04 | -$0.43 | -$0.56 | -$0.55 | -$0.48 | -$0.54 | -$0.49 | -$0.30 | -$48.48 | -$23.92 | -$9.56 | -$10.18 |
| Weighted Average Number Of Diluted Shares Outstanding | 26.2M | 26.1M | 25.9M | 22.8M | 21.6M | 21.2M | 20.8M | 20.7M | 20.7M | 20.6M | 20.5M | 20.5M | 20.1M | 366.1K | 360.7K | ||
| Weighted Average Number Of Shares Outstanding Basic | 26.2M | 26.1M | 25.9M | 22.8M | 21.6M | 21.2M | 20.8M | 20.7M | 20.7M | 20.6M | 20.5M | 20.5M | 20.1M | 366.1K | 360.7K | ||
| Earnings Per Share Basic | $-0.49 | $-0.57 | $-0.53 | $-0.57 | $-0.65 | $-1.04 | $-0.43 | $-0.56 | $-0.55 | $-0.48 | $-0.54 | $-0.49 | $-0.30 | $-48.48 | $-23.92 | ||
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 625.2M | |||
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | |||
| Common Stock Shares Outstanding | 26.2M | 26.1M | 26.1M | 24.2M | 21.7M | 21.6M | 20.8M | 20.8M | 20.7M | 20.6M | 20.6M | 20.5M | 20.4M | 366.3K | |||
| Common Stock Shares Issued | 26.2M | 26.1M | 26.1M | 24.2M | 21.7M | 21.6M | 20.8M | 20.7M | 20.6M | 20.6M | 20.5M | 20.4M | 366.3K | ||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 20.1M | 366.1K | 360.4K | 360.2K |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Depreciation | $756.0K | $619.0K | $522.0K | $412.0K | $168.0K | $75.0K |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $11.1M | $19.1M | $6.3M | $3.9M | $1.9M | $132.0K |
| Stock Issued During Period Value Stock Options Exercised | $793.0K | $2.7M | $728.0K | $184.0K | $23.0K | |
| Interest Paid Net | $5.0M | $3.6M | $1.4M | $59.0K | $1.7M | $2.0M |
| Amortization Of Financing Costs And Discounts | $241.0K | $203.0K | $154.0K | $25.0K | $229.0K | $286.0K |
| Stock Issued During Period Value Employee Stock Purchase Plan | $753.0K | $803.0K | $935.0K | $587.0K | ||
| Stock Issued During Period Value New Issues | $9.0M | $32.5M | $133.2M | |||
| Stock Issued During Period Shares Stock Options Exercised | 294.8K | 510.7K | 144.2K | 150.5K | 59.3K | 175.00 |
| Fair Value Adjustment Of Warrants | $0.00 | $13.3M | $371.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Depreciation | $194.0K | $193.0K | $184.0K | $169.0K | $141.0K | $131.0K | $137.0K | $127.0K | $129.0K | $127.0K | $95.0K | $62.0K | $42.0K | $37.0K | $33.0K | $17.0K | $18.0K |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $2.9M | $2.9M | $2.5M | $2.7M | $2.5M | $11.1M | $1.5M | $1.5M | $1.7M | $929.0K | $1.1M | $793.0K | $474.0K | $624.0K | $61.0K | $31.0K | $32.0K |
| Stock Issued During Period Value Stock Options Exercised | $148.0K | $32.0K | $417.0K | $728.0K | $67.0K | $815.0K | $363.0K | $28.0K | $128.0K | $7.0K | $26.0K | $48.0K | $8.0K | $2.0K | |||
| Interest Paid Net | $1.3M | $770.0K | $188.0K | $0.00 | $500.0K | ||||||||||||
| Amortization Of Financing Costs And Discounts | $59.0K | $48.0K | $31.0K | $0.00 | $68.0K | ||||||||||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $360.0K | $406.0K | $452.0K | $295.0K | |||||||||||||
| Stock Issued During Period Value New Issues | -$45.0K | $9.2M | $19.6M | -$1.0K | $547.0K | $133.2M | |||||||||||
| Stock Issued During Period Shares Stock Options Exercised | 183.8K | 86.6K | 45.2K | 87.6K | |||||||||||||
| Fair Value Adjustment Of Warrants | $0.00 | $3.7M |
Most recent annual filing with the SEC: February 13, 2026
Data sourced from SEC EDGAR public filings as of August 4, 2026.